The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.
December 26th 2024
This listicle highlights 5 major approvals and 5 trial updates in cardiovascular care from 2024.
Paul Whelton from Tulane University: High Sodium Levels Contributing to Global Health Problems
The intake of sodium is becoming a greater problem across the world, but especially in the United States. While people for the most part are not adding sodium to the food themselves the processed foods they are eating contain more sodium than they did in the past.
It was just three years ago that the American College of Cardiology approved new guidelines regarding lowering cholesterol levels. However, in that time new treatments have been approved necessitating the implementation of new potential methods to help this patient population.
Andrew Tershakovec from Merck: Global Study Looks at Ability to Control Cholesterol Levels Locally
The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.
For many years, warfarin has been the primary option for anticoagulation, but recently newer medications have been approved that may provide better options for this patient population. While the clinical trials of the novel oral anticoagulant drugs showed positive results, there were still lingering questions about how they would fare in the field.
Clyde Yancy: Future of Cardiology Looks Bright with New Medications and Treatments
A lot has changed in the field of cardiology over the past few years even disproving ideas that had been held by doctors a decade ago or less. As a result there is hope that patients with a variety of conditions can receive better care than those of the past.
Ahmed Tawakol: Monitoring and Managing Stress to Prevent Cardiovascular Disease Events
Recognizing the connection between stress and cardiovascular disease is one issue, figuring out what to do with this issue to help patients is proving to be a more difficult question to answer.
Nir Uriel: Raising Awareness of Organ Donation and Moving the Field Forward
People in the United States may not be as aware as others around the world about the need or ability to be an organ donor. While this is different depending the country the common thread is that there is a great need for donors until artificial organs become widely available.
There are many factors to consider when looking at a patient's overall cardiac health. When doctors are reading charts with blood pressure, LDL, and others it can make finding the right course of treatment a challenge when looking to find the right medication. Sometimes, especially when it comes to triglycerides alternative medicine can be a valuable option to consider.
Sonal Bhatia from Pfizer: Eliquis Continues to Show Positive Results in Real World Trials
It has been several years since Eliquis was approved as an oral anticoagulant but still more research is being done to show its benefits in helping patients with non-valvular atrial fibrillation.
Jennifer Robinson: Improving Accessibility to PCSK9 Inhibitors One Year Later
It was just one year ago when doctors were excited about being able to offer PCSK9 inhibitors to patients in the hopes of helping them lower their cholesterol. Since that time one considerable challenge they have faced is overcoming the cost of this new class of medication.
Piotr Slomka from Cedars-Sinai: Can Machines Replace Humans in Test Interpretation?
Across the spectrum of medicine machines are being trained to play a larger role in the diagnosis and treatment process. A recent study looked at whether machines are better at predicting the future for a patient and their overall care.